AAAAAA

   
Results: 1-25 | 26-50 | 51-58
Results: 1-25/58
Detection of loss of heterozygosity at chromosome 3p25-26 in primary and metastatic ovarian clear-cell carcinoma: Utilization of microdissection and polymerase chain reaction in archival tissues
Authors: Simsir, A Palacios, D Linehan, WM Merino, MJ Abati, A
Citation: A. Simsir et al., Detection of loss of heterozygosity at chromosome 3p25-26 in primary and metastatic ovarian clear-cell carcinoma: Utilization of microdissection and polymerase chain reaction in archival tissues, DIAGN CYTOP, 24(5), 2001, pp. 328-332
Radiofrequency ablation: A novel approach for treatment of metastatic pheochromocytoma
Authors: Pacak, K Fojo, T Goldstein, DS Eisenhofer, G Walther, MM Linehan, WM Bachenheimer, L Abraham, J Wood, BJ
Citation: K. Pacak et al., Radiofrequency ablation: A novel approach for treatment of metastatic pheochromocytoma, J NAT CANC, 93(8), 2001, pp. 648-649
Cytoreductive laparoscopic radical nephrectomy: the early experience
Authors: Pautler, SE Linehan, WM Walther, MM
Citation: Se. Pautler et al., Cytoreductive laparoscopic radical nephrectomy: the early experience, UROL ONCOL, 6(5), 2001, pp. 193-195
A randomized phase II trial of thalidomide, an angiogenesis inhibitor, in patients with androgen-independent prostate cancer
Authors: Figg, WD Dahut, W Duray, P Hamilton, M Tompkins, A Steinberg, SM Jones, E Premkumar, A Linehan, WM Floeter, MK Chen, CC Dixon, S Kohler, DR Kruger, EA Gubish, E Pluda, JM Reed, E
Citation: Wd. Figg et al., A randomized phase II trial of thalidomide, an angiogenesis inhibitor, in patients with androgen-independent prostate cancer, CLIN CANC R, 7(7), 2001, pp. 1888-1893
Screening for and identification of novel agents directed at renal cell carcinoma
Authors: Mertins, SD Myers, TG Hollingshead, M Dykes, D Bodde, E Tsai, P Jefferis, CA Gupta, R Linehan, WM Alley, M Bates, SE
Citation: Sd. Mertins et al., Screening for and identification of novel agents directed at renal cell carcinoma, CLIN CANC R, 7(3), 2001, pp. 620-633
Molecular cytogenetic characterization of early and late renal cell carcinomas in Von Hippel-Lindau disease
Authors: Phillips, JL Ghadimi, BM Wangsa, D Padilla-Nash, H Worrell, R Hewitt, S Walther, M Linehan, WM Klausner, RD Ried, T
Citation: Jl. Phillips et al., Molecular cytogenetic characterization of early and late renal cell carcinomas in Von Hippel-Lindau disease, GENE CHROM, 31(1), 2001, pp. 1-9
Pigmented renal clear cell carcinoma with melanocytic differentiation
Authors: Lei, JY Middleton, LP Guo, XD Duray, PH McWilliams, G Linehan, WM Merino, MJ
Citation: Jy. Lei et al., Pigmented renal clear cell carcinoma with melanocytic differentiation, HUMAN PATH, 32(2), 2001, pp. 233-236
Treatment of renal-cell cancer by transplantation of allogeneic stem cells. Reply
Authors: Childs, R Barrett, AJ Linehan, WM
Citation: R. Childs et al., Treatment of renal-cell cancer by transplantation of allogeneic stem cells. Reply, N ENG J MED, 344(2), 2001, pp. 138-138
Lack of retroperitoneal lymphadenopathy predicts survival of patients withmetastatic renal cell carcinoma
Authors: Vasselli, JR Yang, JC Linehan, WM White, DE Rosenberg, SA Walther, MM
Citation: Jr. Vasselli et al., Lack of retroperitoneal lymphadenopathy predicts survival of patients withmetastatic renal cell carcinoma, J UROL, 166(1), 2001, pp. 68-72
Parenchymal sparing surgery in a patient with multiple bilateral papillaryrenal cancer
Authors: Chernoff, A Choyke, PL Linehan, WM Walther, MM
Citation: A. Chernoff et al., Parenchymal sparing surgery in a patient with multiple bilateral papillaryrenal cancer, J UROL, 165(5), 2001, pp. 1623-1624
Expression studies and mutational analysis of the androgen regulated homeobox gene NKX3.1 in benign and malignant prostate epithelium
Authors: Ornstein, DK Cinquanta, M Weiler, S Duray, PH Emmert-Buck, MR Vocke, CD Linehan, WM Ferretti, JA
Citation: Dk. Ornstein et al., Expression studies and mutational analysis of the androgen regulated homeobox gene NKX3.1 in benign and malignant prostate epithelium, J UROL, 165(4), 2001, pp. 1329-1334
Parenchymal sparing surgery in patients with hereditary renal cell carcinoma: 10-year experience
Authors: Herring, JC Enquist, EG Chernoff, A Linehan, WM Choyke, PL Walther, MM
Citation: Jc. Herring et al., Parenchymal sparing surgery in patients with hereditary renal cell carcinoma: 10-year experience, J UROL, 165(3), 2001, pp. 777-781
Intraoperative ultrasound during renal parenchymal sparing surgery for hereditary renal cancers: A 10-year experience
Authors: Choyke, PL Pavlovich, CP Daryanani, KD Hewitt, SM Linehan, WM Walther, MM
Citation: Pl. Choyke et al., Intraoperative ultrasound during renal parenchymal sparing surgery for hereditary renal cancers: A 10-year experience, J UROL, 165(2), 2001, pp. 397-400
Pheochromocytomas in von Hippel-Lindau syndrome and multiple endocrine neoplasia type 2 display distinct biochemical and clinical phenotypes
Authors: Eisenhofer, G Walther, MM Huynh, TT Li, ST Bornstein, SR Vortmeyer, A Mannelli, M Goldstein, DS Linehan, WM Lenders, JWM Pacak, K
Citation: G. Eisenhofer et al., Pheochromocytomas in von Hippel-Lindau syndrome and multiple endocrine neoplasia type 2 display distinct biochemical and clinical phenotypes, J CLIN END, 86(5), 2001, pp. 1999-2008
The consequences of chromosomal aneuploidy on gene expression profiles in a cell line model for prostate carcinogenesis
Authors: Phillips, JL Hayward, SW Wang, YH Vasselli, J Pavlovich, C Padilla-Nash, H Pezullo, JR Ghadimi, BM Grossfeld, GD Rivera, A Linehan, WM Cunha, GR Ried, T
Citation: Jl. Phillips et al., The consequences of chromosomal aneuploidy on gene expression profiles in a cell line model for prostate carcinogenesis, CANCER RES, 61(22), 2001, pp. 8143-8149
Recent advances in genetics, diagnosis, localization, and treatment of pheochromocytoma
Authors: Pacak, K Linehan, WM Eisenhofer, G Walther, MM Goldstein, DS
Citation: K. Pacak et al., Recent advances in genetics, diagnosis, localization, and treatment of pheochromocytoma, ANN INT MED, 134(4), 2001, pp. 315-329
Birt-Hogg-Dube syndrome, a genodermatosis associated with spontaneous pneumothorax and kidney neoplasia, maps to chromosome 17p11.2
Authors: Schmidt, LS Warren, MB Nickerson, ML Weirich, G Matrosova, V Toro, JR Turner, ML Duray, P Merino, M Hewitt, S Pavlovich, CP Glenn, G Greenberg, CR Linehan, WM Zbar, B
Citation: Ls. Schmidt et al., Birt-Hogg-Dube syndrome, a genodermatosis associated with spontaneous pneumothorax and kidney neoplasia, maps to chromosome 17p11.2, AM J HU GEN, 69(4), 2001, pp. 876-882
Molecular analysis of the von Hippel-Lindau disease gene
Authors: Chernoff, A Kasparcova, V Linehan, WM Stolle, CA
Citation: A. Chernoff et al., Molecular analysis of the von Hippel-Lindau disease gene, METH MOL M, 53, 2001, pp. 193-216
Genetic alterations in prostatic intraepithelial neoplasia (PIN)
Authors: Duray, PH Ornstein, DK Vocke, CD Hewitt, SM Cole, KA Gillespie, JW Englert, CR Petricoin, EF Krizman, DB Linehan, WM Emmert-Buck, MR
Citation: Ph. Duray et al., Genetic alterations in prostatic intraepithelial neoplasia (PIN), CONT CANC R, 2001, pp. 141-161
Molecular profiling of clinical tissue specimens - Feasibility and applications
Authors: Emmert-Buck, MR Strausberg, RL Krizman, DB Bonaldo, MF Bonner, RF Bostwick, DG Brown, MR Buetow, KH Chuaqui, RF Cole, KA Duray, PH Englert, CR Gillespie, JW Greenhut, S Grouse, L Hillier, LW Katz, KS Klausner, RD Kuznetzov, V Lash, AE Lennon, G Linehan, WM Liotta, LA Marra, MA Munson, PJ Ornstein, DK Prabhu, VV Prange, C Schuler, GD Soares, MB Tolstoshev, CM Vocke, CD Waterston, RH
Citation: Mr. Emmert-buck et al., Molecular profiling of clinical tissue specimens - Feasibility and applications, J MOL DIAGN, 2(2), 2000, pp. 60-66
Characterization of intracellular prostate-specific antigen from laser capture microdissected benign and malignant prostatic epithelium
Authors: Ornstein, DK Englert, C Gillespie, JW Paweletz, CP Linehan, WM Emmert-Buck, MR Petricoin, EF
Citation: Dk. Ornstein et al., Characterization of intracellular prostate-specific antigen from laser capture microdissected benign and malignant prostatic epithelium, CLIN CANC R, 6(2), 2000, pp. 353-356
Serum endostatin levels are elevated and correlate with serum vascular endothelial growth factor levels in patients with stage IV clear cell renal cancer
Authors: Feldman, AL Tamarkin, L Paciotti, GF Simpson, BW Linehan, WM Yang, JC Fogler, WE Turner, EM Alexander, HR Libutti, SK
Citation: Al. Feldman et al., Serum endostatin levels are elevated and correlate with serum vascular endothelial growth factor levels in patients with stage IV clear cell renal cancer, CLIN CANC R, 6(12), 2000, pp. 4628-4634
Development of a prostate cDNA microarray and statistical gene expression analysis package
Authors: Carlisle, AJ Prabhu, VV Elkahloun, A Hudson, J Trent, JM Linehan, WM Williams, ED Emmert-Buck, MR Liotta, LA Munson, PJ Krizman, DB
Citation: Aj. Carlisle et al., Development of a prostate cDNA microarray and statistical gene expression analysis package, MOL CARCINO, 28(1), 2000, pp. 12-22
Suramin administration is associated with a decrease in serum calcium levels
Authors: Walther, MM Rehak, NN Venzon, D Myers, CE Linehan, WM Figg, WD
Citation: Mm. Walther et al., Suramin administration is associated with a decrease in serum calcium levels, WORLD J URO, 18(6), 2000, pp. 388-391
Rapid protein display profiling of cancer progression directly from human tissue using a protein biochip
Authors: Paweletz, CP Gillespie, JW Ornstein, DK Simone, NL Brown, MR Cole, KA Wang, QH Huang, J Hu, N Yip, TT Rich, WE Kohn, EC Linehan, WM Weber, T Taylor, P Emmert-Buck, MR Liotta, LA Petricoin, EF
Citation: Cp. Paweletz et al., Rapid protein display profiling of cancer progression directly from human tissue using a protein biochip, DRUG DEV R, 49(1), 2000, pp. 34-42
Risultati: 1-25 | 26-50 | 51-58